Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pathos

Request full access

Reimagining drug discovery and development through the lens of technology, with an AI intelligence platform

Chicago, United StatesFounded 2022Biotech & Life Sciences

About Pathos

Pathos is a biotechnology company that operates at the intersection of artificial intelligence and oncology. The company's core mission is to accelerate the development of cancer drugs by leveraging a sophisticated platform that integrates vast amounts of oncology data, including genomic information.

Pathos utilizes advanced AI and machine learning algorithms to analyze this complex data, aiming to re-engineer the drug development process. This data-driven approach allows the company to identify and validate novel therapeutic targets and biomarkers, ultimately leading to more effective and personalized cancer treatments.

The company's business model is centered on collaborating with pharmaceutical and biotechnology partners to advance their oncology pipelines. By providing its AI-powered platform and insights, Pathos helps its clients to de-risk drug development, reduce timelines, and increase the probability of success for new cancer therapies. The company serves a clientele of researchers, drug developers, and clinicians in the oncology space.

Source: Dealroom company data

Pathos in the Chicago ecosystem

Live from Dealroom

The Pathos office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • NEA
  • Lightbank
  • Revolution
  • Builders VC
Employees mapped 98 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$39k

1 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Pathos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.